Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Phase IIB Study Evaluating the Efficacy of Mesdopetam on Daily ON-time Without Troublesome Dyskinesia in Patients With Parkinson's Disease

NCT04435431 is registered in ClinicalTrials.gov with Integrative Research Laboratories AB as lead sponsor.

NCT NCT04435431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Phase IIB Study Evaluating the Efficacy of Mesdopetam on Daily ON-time Without Troublesome Dyskinesia in Patients With Parkinson's Disease
Lead sponsor
Integrative Research Laboratories AB
Phase
Phase 2
Overall status
Completed
Start date
October 29, 2020
Completion date
December 9, 2022
Enrollment
155 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease